IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acorda Therapeutics Inc

CUSIP: 00484MAC0 | TRACE | 10 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Highbridge Capital Management LLC45,283,000
1.1% of portfolio›$31.0M
Soros Fund Management LLC27,951,000
0.3% of portfolio›$15.9M
Canyon Capital Advisors LLC25,875,000
1.5% of portfolio›$13.7M
Wells Fargo & Company5,018,000
0.0% of portfolio›$2.9M
HN Saltoro Capital, LP1,500,000
1.1% of portfolio›$855.0K
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Highbridge Capital Management LLC
45,283,000$31.0M1.1%ValueVery HighNew York, NY2024-05-10
Soros Fund Management LLC
27,951,000$15.9M0.3%CoreVery HighNew York, NY2024-05-15
Canyon Capital Advisors LLC
25,875,000$13.7M1.5%YieldHighDallas, TX2024-05-15
Wells Fargo & Company
5,018,000$2.9M0.0%CoreLowSan Francisco, CA2024-05-10
HN Saltoro Capital, LP
1,500,000$855.0K1.1%N/AN/ADallas, TX2024-05-15
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2024-05-01